Literature DB >> 16507748

Estrogen and mitochondria: a new paradigm for vascular protection?

Sue Piper Duckles1, Diana N Krause, Christopher Stirone, Vincent Procaccio.   

Abstract

Mitochondrial dysfunction has been implicated as a cause of age-related disorders, and the mitochondrial theory of aging links aging, exercise, and diet. Endothelial dysfunction is a key paradigm for vascular disease and aging, and there is considerable evidence that exercise and dietary restriction protect against cardiovascular disease. Recent studies demonstrate that estrogen receptors are present in mitochondria and that estrogen promotes mitochondrial efficiency and decreases oxidative stress in the cerebral vasculature. Chronic estrogen treatment increases mitochondrial capacity for oxidative phosphorylation while decreasing production of reactive oxygen species. The effectiveness of estrogen against age-related cardiovascular disorders, including stroke, may thus arise in part from hormonal effects on mitochondrial function. Estrogen-mediated mitochondrial efficiency may also be a contributing factor to the longer lifespan of women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507748     DOI: 10.1124/mi.6.1.6

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  36 in total

1.  Vascular damage in obese female rats with hypoestrogenism.

Authors:  Luis Angel Lima-Mendoza; Juventino Colado-Velázquez; Patrick Mailloux-Salinas; Josué V Espinosa-Juárez; Norma L Gómez-Viquez; Tzindilu Molina-Muñoz; Fengyang Huang; Guadalupe Bravo
Journal:  J Physiol Biochem       Date:  2013-08-31       Impact factor: 4.158

2.  A study of the relationship of metabolic MR parameters to estrogen dependence in breast cancer xenografts.

Authors:  Ting Liu; Kavindra Nath; Weixia Liu; Rong Zhou; I-Wei Chen
Journal:  NMR Biomed       Date:  2015-07-14       Impact factor: 4.044

Review 3.  Sex differences in stroke: the contribution of coagulation.

Authors:  Meaghan Roy-O'Reilly; Louise D McCullough
Journal:  Exp Neurol       Date:  2014-02-19       Impact factor: 5.330

4.  Association of estrogen receptor β gene polymorphisms with vascular dementia in women.

Authors:  Jiawei Xin; Junjian Zhang; Yongzhe Gao; Li Xiong
Journal:  Neurol Sci       Date:  2011-12-20       Impact factor: 3.307

5.  Endogenous ovarian hormones affect mitochondrial efficiency in cerebral endothelium via distinct regulation of PGC-1 isoforms.

Authors:  Martin F Kemper; Yuanzi Zhao; Sue P Duckles; Diana N Krause
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-24       Impact factor: 6.200

Review 6.  Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Authors:  Jia Yao; Roberta Diaz Brinton
Journal:  Adv Pharmacol       Date:  2012

7.  Mitochondrial effects of estrogen are mediated by estrogen receptor alpha in brain endothelial cells.

Authors:  Ali Razmara; Lorraine Sunday; Chris Stirone; Xiao Bo Wang; Diana N Krause; Sue P Duckles; Vincent Procaccio
Journal:  J Pharmacol Exp Ther       Date:  2008-03-19       Impact factor: 4.030

8.  Pretreatment with a single estradiol-17beta bolus activates cyclic-AMP response element binding protein and protects CA1 neurons against global cerebral ischemia.

Authors:  A P Raval; I Saul; K R Dave; R A DeFazio; M A Perez-Pinzon; H Bramlett
Journal:  Neuroscience       Date:  2009-03-09       Impact factor: 3.590

Review 9.  Vascular actions of estrogens: functional implications.

Authors:  Virginia M Miller; Sue P Duckles
Journal:  Pharmacol Rev       Date:  2008-06-25       Impact factor: 25.468

10.  Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.

Authors:  Reagan L Ross; Michelle R Serock; Raouf A Khalil
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.